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Objective. To evaluate diagnosis, age of referral, karyotype, and sex of rearing of cases with disorders of sex development (DSD)
with ambiguous genitalia. Methods. Retrospective study during 23 years at outpatient clinic of a referral center. Results. There
were 408 cases; 250 (61.3%) were 46,XY and 124 (30.4%) 46,XX and 34 (8.3%) had sex chromosomes abnormalities. 189 (46.3%)
had 46,XY testicular DSD, 105 (25.7%) 46,XX ovarian DSD, 95 (23.3%) disorders of gonadal development (DGD), and 19 (4.7%)
complex malformations.Themain etiology of 46,XX ovarian DSDwas salt-wasting 21-hydroxylase deficiency. In 46,XX and 46,XY
groups, other malformations were observed. In the DGD group, 46,XY partial gonadal dysgenesis, mixed gonadal dysgenesis, and
ovotesticular DSD were more frequent. Low birth weight was observed in 42 cases of idiopathic 46,XY testicular DSD.The average
age at diagnosis was 31.7 months. The final sex of rearing was male in 238 cases and female in 170. Only 6.6% (27 cases) needed
sex reassignment. Conclusions. In this large DSD sample with ambiguous genitalia, the 46,XY karyotype was the most frequent;
in turn, congenital adrenal hyperplasia was the most frequent etiology. Malformations associated with DSD were common in all
groups and low birth weight was associated with idiopathic 46,XY testicular DSD.
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1. Introduction
One of many possible medical emergencies in newborns
is genital ambiguity that has significant importance both
immediately after birth, such as congenital adrenal hyperpla-
sia and certain malformation syndromes that may present
potential risk to child’s life, and in the long term, such
as unresolved sex definition that may cause irreversible
psychosocial effects for patients and their families [1, 2]. An
experiencedmultidisciplinary team is required for the proper
care of children with ambiguous genitalia, which is usually
found in tertiary and university care centers [1–3].
The incidence of disorders of sex development (DSD) is
not fully known. In 2000, Fausto-Sterling suggested that it
corresponds to 1.7%of live births [4].However, two years later
Sax questioned this estimative arguing that the author had
included patients without genital ambiguity, such as those
with Turner and Klinefelter syndromes and the nonclassical
form of congenital adrenal hyperplasia and suggested that the
incidence of DSD with genital ambiguity would be actually
0.0018% [5].
The Chicago Consensus in 2006 [1], updated in 2016
[2], established a classification for DSD based on karyotype.
However, some authors have questioned this classification
and proposed a different classification based on type of
gonadal tissue [6–9].
Therefore it is evident that several issues on DSD are still
under discussion. In order to add insights to the DSD study,
such as classification, frequency of different diagnoses, sex
definition, and sex reassignment, the aim of this study was
to describe the experience of the Interdisciplinary Group of
Study of SexDetermination andDifferentiation (GIEDDS) in
the School of Medicine (FCM) and Clinical Hospital (HC)
at the State University of Campinas (UNICAMP), Brazil,
over 23 years in the care of newborns, children, adolescents,
and adults with DSD and genital ambiguity, analyzing the
frequency of each cause, the age at diagnosis, the sex of
rearing, and reassignment.
2. Materials and Methods
All cases of ambiguous genitalia seen at the Outpatient Clinic
of GIEDDS, FCM, HC, UNICAMP, between January 1989
and December 2011 were included in the study. During this
period, the same medical team of pediatric endocrinolo-
gists, geneticists, psychologists, and pediatric surgeons had
followed every case. Karyotyping had been performed in
the Cytogenetics Laboratory in the Department of Medical
Genetics at FCM, UNICAMP, scoring at least 30 metaphases.
Hormonal and biochemical tests were performed in the
Laboratory of Physiology at HC, UNICAMP. Molecular tests
were performed at the Laboratory of Human Molecular
Genetics at the Center of Molecular Biology and Genetic
Engineering (CBMEG), UNICAMP.
The criteria used for the definition of genital ambi-
guity were those set by the Chicago Consensus in 2006
[1]. The cases were classified in four major groups based
on karyotype and gonadal tissue: (1) disorders of gonadal
development (DGD) irrespective of the karyotype; (2) 46,XX
ovarian DSD; (3) 46,XY testicular DSD; and (4) complex
malformations of the external genitalia, defined in this study
as others (see Supplementary Material available online at
http://dx.doi.org/10.1155/2016/4963574).
We evaluated the following data: age (in months) at the
first visit, birth weight (in grams), social sex at the first and
last visit, and etiologic diagnosis.
Data were stored in SPSS 16.0 spreadsheets and presented
as absolute and relative frequency. The Mann-Whitney test
was used to analyze age differences between the four major
groups of diseases, with 𝛼 = 0.05.
3. Results
Over the 23 years of the study, our team attended 408
cases of genital ambiguity. Among them, 189 (46.3%) had
46,XY testicular DSD, 105 (25.7%) 46,XX ovarian DSD, 95
(23.3%) a DGD, and 19 (4.7%) other complex malformations
(Table 1). Regarding the karyotypes, 250 (61.3%) were 46,XY,
124 (30.4%) were 46,XX, and 34 (8.3%) had numerical or
structural abnormalities of sex chromosomes with or without
mosaicism.
Among the 105 cases of 46,XX ovarian DSD, the great
majority had congenital adrenal hyperplasia (𝑛 = 69,
65.7%); 68 had 21-hydroxylase deficiency distributed between
simple virilizing form including one case with associated
45,X/46,XXTurner syndrome (𝑛 = 17) and salt-wasting form
(𝑛 = 51) and one case of P450 oxidoreductase deficiency;
all had molecular confirmation. Among patients with syn-
dromic features (𝑛 = 10, 9.5%), three had VATER associ-
ation, one had Seckel syndrome, one had Wolf-Hirschhorn
syndrome [46,XX,del(4p)], one had caudal regression, and
four remained with unknown etiology (Table 1).
In the 46,XY testicular DSD group (𝑛 = 189), most
were syndromic (𝑛 = 40) or idiopathic (𝑛 = 77). It is
relevant to mention that 42 idiopathic cases (22%) presented
birth weight < 2,500 g (from 700 to 2,500 g; mean = 1,934 g).
Regarding the group with a defined diagnosis, androgen
receptor defects (𝑛 = 25), 5𝛼-reductase type 2 deficiency
(𝑛 = 20), and hypogonadotropic hypogonadism (𝑛 = 12),
including six with associated hypopituitarism, were found
with higher frequencies, followed by the group of defects
in testosterone synthesis that included one patient with
HSD3B2 deficiency, one with CYP17A1 deficiency, and two
with HSD17B3 deficiency. All of them had their diagnosis
confirmed by molecular studies. Cases of syndromic features
included VATER association (𝑛 = 3), CHARGE syndrome
(𝑛 = 3), Aarskog syndrome (𝑛 = 3), foetal alcohol syndrome
(𝑛 = 3), Robinow syndrome (𝑛 = 1), GBBB syndrome
(𝑛 = 1), Noonan syndrome (𝑛 = 1), and four with autosomal
chromosome abnormalities [46,X,add(1)(q43), 46,XY,del(4p),
46,XY,add(10)(q26), 46,XY,t(13;14)(q11;q11)]; 21 remained
with unknown etiology (Table 1).
Regarding 95 cases included in the DGD group, there was
a predominance of partial and mixed gonadal dysgenesis,
followed by ovotesticular DSD. The distribution of different
karyotypes in ovotesticular DSD was 46,XX (𝑛 = 8), 46,XY
(𝑛 = 6) and 46,XX/46,XY (𝑛 = 2); other karyotypes such as
47,XXY, 46XX/47,XXY/48,XXYY, 45,X/46,XY, 45,X/47,XYY,
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Table 1: Frequencies of etiological diagnosis in 408 consecutive cases of DSD with ambiguous genitalia followed at GIEDDS, UNICAMP,
between January 1989 and December 2011.
Syndromic diagnosis Etiologic diagnosis 𝑁 𝐹1 𝐹2
46,XX ovarian DSD
Congenital adrenal
hyperplasia 69 16.9 65.7
Isolated clitoromegaly 19 4.7 18.1
Syndromic 10 2.5 9.5
Teratogenic1 2 0.5 1.9
Idiopathic 5 1.2 4.8
Total 105 25.8 100.0
46,XY testicular DSD
Hypogonadotropic
hypogonadism 12 2.9 6.3
Defect in the
LH/hCG receptor 2 0.5 1.1
Synthesis of
testosterone defect 4 1.0 2.1
Androgen
insensitivity
Total 15 3.7 7.9
Partial 10 2.5 5.3
5𝛼-Reductase type 2
deficiency 20 4.9 10.6
Muller duct
persistence 4 1.0 2.1
Teratogenic1 5 1.2 2.6
Syndromic 40 9.8 21.2
Idiopathic 77 18.8 40.8
Total 189 46.3 100.0
Disorders of gonadal
development
Ovotesticular DSD 22 5.4 23.1
Mixed gonadal
dysgenesis 25 6.1 26.3
Partial gonadal
dysgenesis
SRY mutation 2 0.5 2.1
WT1mutation 5 1.2 5.3
NR5A1mutation 9 2.3 9.5
No defined cause 22 5.4 23.1
46,XX testicular DSD 3 0.7 3.2
Testicular regression
syndrome 7 1.7 7.4
Total 95 23.3 100.0
Others
Epispadias 4 1.0 21.0
Penis malformation 5 1.2 26.3
Clitoris malformation 6 1.5 31.7
Multiple
malformations 4 1.0 21.0
Total 19 4.7 100.0
𝐹1 = relative frequency (%) in relation to the total number of cases of genital ambiguity (408); 𝐹2 = relative frequency (%) in the number of cases of the
diagnostic group (105 46,XX ovarian DSD; 189 46,XY testicular DSD; 95 DDG and 19 others); 1 = use of drugs by the mother during pregnancy.
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Figure 1: Distribution of initial and final sex assignments in 408
consecutive cases of DSD with ambiguous genitalia followed at
GIEDDS, UNICAMP, between January 1989 and December 2011.
45,X/46,X+mar(Y+), and 45,X/47,XY,+mar(Y+) were also
found (𝑛 = 1, resp.). Different karyotypes were also observed
within the group of patients with mixed gonadal dysgenesis.
From a total of 25 patients 12 were 45,X/46,XY, and the
remainders had numerical and/or structural abnormalities:
45,X/46,X+mar(Y+) (𝑛 = 4), 45,X/46,XY/47,XY,+mar(Y+)
(𝑛 = 3), and 45,X/46,Xi(Yq), 45,X/46,X,del(Yq), 45,X/46,
X,idic(Yq), 45,X/46,Xi(Yq)/47,Xi(Yq),i(Yq), 45,X/46,Xi(Yq)/
46,X,r(Y)/47,Xi(Yq),r(Y), and 45,Xinv(9)(p13;q21)/46,XY,
inv(9)(p13) (one case of each). Among patients with testicular
regression syndrome, one had bilateral agonadism and six
had bilateral anorchia (Table 1).
Finally, the distribution of the diagnosis for the remaining
19 cases was as follows: five cases of penis malformation
including partial penoscrotal inversion (𝑛 = 2), penis agen-
esis (𝑛 = 1), abnormal penis rotation (𝑛 = 1), and penoscrotal
adherence (𝑛 = 1); clitoral malformation included clitoris
agenesis (𝑛 = 4), severe clitoris hypoplasia (𝑛 = 1), and
lipoma on the clitoris (𝑛 = 1); diagnosis in cases withmultiple
complex malformations included exstrophy of the cloaca and
cardiomyopathy (𝑛 = 2), Prune-Belly syndrome (𝑛 = 1), and
perineal lipoma (𝑛 = 1) (Table 1).
Analysis of sex definition in the 408 patientswith ambigu-
ous genitalia revealed that 111 (27.2%) patients came to the
first consultation without sex definition; after clinical and
laboratorial investigation 52 were assigned as male and 59
female (Figure 1).We also observed that 15 cases from the total
of 189 who had initial registration as male were reassigned
as female; from 108 who had initial registration as female 12
were reassigned as male (Figure 1).Therefore, 6.6% (27 cases)
had sex reassignment, all of the them before one year of age,
except for the patients with 5𝛼-reductase type 2 deficiency.
Table 2 shows the distribution according to initial and
final sex and clinical and laboratorial diagnosis. Considering
those 15 cases that were initially registered as male and were
reassigned as female, seven had 46,XX ovarian DSD due
to congenital adrenal hyperplasia, four had mixed gonadal
dysgenesis, three had ovotesticular DSD, and one had 46,XY
idiopathic testicular DSD. In turn, among the 12 females
who were reassigned as males seven had 5𝛼-reductase type
2 deficiency, two had partial gonadal dysgenesis, one had
mixed gonadal dysgenesis, one had ovotesticular DSD, and
one had syndromic 46,XY testicular DSD. All cases of 46,XX
ovarian DSD had female final sex assignment. In the 46,XY
testicular DSD group, the great majority had male final sex
assignment, except for cases of LHCG receptor defect, defects
of testosterone synthesis, and complete androgen insensitiv-
ity. Within the DGD group, there was not a predominance
of either sex, except for 46,XX testicular DSD and testicular
regression syndrome (except one case of agonadism), all of
them assigned asmales. For other causes of genital ambiguity,
in general, the final sex followed the genotypic sex.
One hundred and ninety-three (47.3%) out of 408 cases
had the first visit in GIEDDS, UNICAMP, before six months
of age (Table 2). The distribution according to karyotype was
46,XX (𝑛 = 82), 46,XY (𝑛 = 95), and numerical or structural
abnormalities of sex chromosomes (𝑛 = 16). Among them,
105 did not have a sex assignment; 51 weremale and 37 female;
95 and 98 had final sex assignment as male and female,
respectively. In this group the diagnosis was as follows: 46,XX
ovarian DSD (𝑛 = 74), 46,XY testicular DSD (𝑛 = 74), DGD
(𝑛 = 37), and other malformations (𝑛 = 8).
The average age at the first visit was 31.7 months (about
three years); it was significantly lower in the 46,XX ovarian
DSD group than in the group of 46,XY testicular DSD
(Mann-Whitney test, 𝑝 < 0.0001) and DGD (Mann-Whitney
test; 𝑝 < 0.0001), but it did not differ significantly from
the group of other malformations (Mann-Whitney test, 𝑝 =
0.06). The 46,XY testicular DSD group did not differ from
the DGD group (Mann-Whitney test, 𝑝 = 0.975) and from
the group of other malformations (Mann-Whitney test, 𝑝 =
0.125); the DGD group did not differ from the group of other
malformations (Mann-Whitney test, 𝑝 = 0.19) (Table 3).
4. Discussion
This is a descriptive study with a large case series of DSDwith
genital ambiguity, investigated over a long period by the same
clinical and laboratory staff. To our knowledge, this is the
largest consecutive series of DSD cases with genital ambiguity
under a single service in the literature.
Over 23 years, 408 cases of genital ambiguity had been
studied with a predominance of 46,XY karyotype (61.3%),
twice as frequent as 46,XX (30.4%). Numerical or struc-
tural abnormalities of sex chromosomes with or without
mosaicism were found in less than 10%. Our results were
similar to those described by Cox et al. [10], who analyzed
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Table 2: Frequencies of initial and final sex distributed according to aetiologic diagnosis of 408 consecutive cases of DSD with ambiguous
genitalia followed at GIEDDS, UNICAMP, between January 1989 and December 2011.
Etiologic diagnosis Age ≤ 6months
Initial sex Final sex
M F I M F
46,XX ovarian DSD
Congenital adrenal
hyperplasia 50 7 36 26 0 69
Isolated clitoromegaly 14 0 10 9 0 19
Teratogenic 1 0 2 0 0 2
Syndromic 6 0 7 3 0 10
Idiopathic 3 0 3 2 0 5
46,XY testicular DSD
Hypogonadotropic
hypogonadism 4 12 0 0 12 0
Defect in the LH/hCG
receptor 0 0 2 0 0 2
Defective synthesis of
testosterone 1 1 3 0 1 3
Androgen insensitivity
Total 2 0 14 1 0 15
Partial 4 9 0 1 9 1
5𝛼-Reductase type 2
deficiency 5 2 12 6 13 7
Muller duct persistence 1 4 0 0 4 0
Teratogenic 3 4 0 1 5 0
Syndromic 21 29 1 10 39 1
Idiopathic 33 57 1 19 76 1
Disorders of gonadal
development
Ovotesticular DSD 8 13 4 5 10 12
Mixed gonadal
dysgenesis 13 17 1 7 17 8
Partial gonadal
dysgenesis
SRY mutation 1 0 0 2 2 0
WT1mutation 2 1 2 2 3 2
NR5A1mutation 4 4 2 3 8 1
Undefined cause 8 11 3 8 18 4
46,XX testicular DSD 1 2 0 1 3 0
Testicular regression
syndrome 0 6 1 0 6 1
Others
Epispadias 2 4 0 0 4 0
Penis malformation 2 3 0 2 5 0
Clitoris malformation 2 0 5 1 0 6
Multiple malformations 2 2 0 2 3 1
Total 193 189 108 111 238 170
Table 3: Variation of the age at the first visit for 408 consecutive cases of DSD with ambiguous genitalia followed at GIEDDS, UNICAMP,
between January 1989 and December 2011.
Diagnostic 𝑛 Age (months)
Mean Median SD Minimum Maximum
46,XX ovarian DSD 105 15.9 1.7 33.7 0.0 173.0
46,XY testicular DSD 189 35.4 13.7 60.1 0.1 301.0
Disorders of gonadal differentiation 95 45.3 9.0 69.3 0.2 324.0
Others 19 14.8 8.1 22.4 0.3 96.2
Total 408 31.7 7.0 56.7 0.0 324.0
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649 cases of an international register and found that 460
(71%) were 46,XY and 121 (19%) 46,XX and 68 (10%) had
sex chromosomes abnormalities, confirming that DSD with
genital ambiguity are more frequent in patients with 46,XY
karyotype, due to the complexity of male sexual differentia-
tion [11].
One-fourth of the total number of patients had a diag-
nosis of 46,XX ovarian DSD, mainly congenital adrenal
hyperplasia due to 21𝛼-hydroxylase deficiency, confirming
the high frequency of this disease in all DSD samples [10, 12].
The frequency of the salt-wasting form was also similar to
that found in several population studies [13], confirming that
it is the most relevant etiology of DSD due to both its high
frequency and the high risk of death. Isolated clitoromegaly
and syndromic features were also observed, which shows
the importance of a wide range of clinical, hormonal, and
molecular investigation for DSD, as well as the significance of
the finding of dysmorphisms and associated malformations
in cases of genital ambiguity [10, 14, 15].
When it concerns DSD with 46,XY karyotype, there are
many challenges for the medical staff and for patients and
families, because male sexual differentiation is complex and
many differential diagnoses require time and experienced
medical staff to establish an accurate diagnosis as quickly as
possible [11]. Almost half of the cases (189/408) were of 46,XY
testicular DSD and within this group prevalent diagnoses
were those of defects in androgen receptor (both partial and
complete forms) and 5𝛼-reductase type 2 deficiency [16–18].
Such differential diagnoses are challenging in the newborn,
especiallywhen there is no history of consanguinity or similar
cases in the family [16, 19, 20], which challenges sex definition
for those children [21]. Furthermore, among 46,XY testicular
DSD, we should also highlight cases of hypogonadotropic
hypogonadism with or without hypopituitarism, in which
the presence of micropenis with cryptorchidism and without
hypospadias strongly suggests this diagnosis [22]. Among less
frequent etiologies of 46,XY testicularDSDwith amonogenic
origin there were defects in the LHCG receptor and in testos-
terone synthesis and persistence ofMu¨llerian ducts. Even less
frequent were those cases associated with the use of drugs
by the mother during pregnancy. On the other hand, among
the most frequent cases in the 46,XY DSD testicular group
were those with syndromic features, once again showing the
importance of assessment of dysmorphic features of these
patients [10] and the idiopathic forms. In the latter, half of
the patients weighed less than 2,500 grams at birth.The asso-
ciation of small for gestational age and genital ambiguity in
newborns with 46,XY karyotype is frequently reported in the
literature [10, 15, 23, 24], but the explanation is still unclear.
Fetal gonadal determination is influenced by many genes
(SRY, NR5A1, WT1, SOX9, etc.) and may be disrupted by
abnormalities in sex chromosomes [8–11]. With techniques
of genomic sequencing, new genes are emerging as par-
ticipants in the complex process of gonadal development
[25]. The DGD group includes diseases in which gonadal
differentiation was inadequate or incomplete; therefore diag-
noses required histological confirmation by an experienced
pathologist [26]. For diseases associated with chromosomal
and genetic abnormalities, it was necessary to perform
laboratorial tests using conventional cytogenetic, molecular
cytogenetic, and molecular genetic techniques [27]. Among
95 cases ofDGD,we observed a prevalence of the 46,XY kary-
otype, followed by sex chromosomes abnormalities; in turn,
the 46,XX karyotype was less frequent. Among DGD cases,
partial gonadal dysgenesis was themost frequent, followed by
mixed gonadal dysgenesis and ovotesticular DSD. Mutations
were identified in a specific gene in only 16 out of the 39 cases
of partial gonadal dysgenesis [28–33]. The identification of
a mutation in the specific gene is important for the follow-
up of these cases, particularly mutations in WT1 that are
associated with risk of kidney cancer and gonadal and renal
failure [30, 31]. NR5A1 mutations are associated with risk of
adrenal insufficiency and primary ovarian failure [32–34]. In
a family with mutation in SRY, there was a wide spectrum of
XY gonadal dysgenesis manifestation, varying from partial to
complete forms [28]. Other cases with no known mutations
are candidates for genomic approaches [25]. In cases of
partial gonadal dysgenesis the prognosis of spontaneous
puberty in patients assigned as males is relatively good [35].
Cases of mixed gonadal dysgenesis, mainly those with 45,X
mosaicism, require follow-up for diseases associated with
Turner syndrome and short stature [36]. Cases of ovotesticu-
lar DSD, which may occur in the presence of any chromoso-
mal constitution, represent a challenge for the sex of rearing
definition, prognosis, and etiologic diagnosis [37–39]. Clini-
calmanagement in cases of ovotesticularDSDdepends on the
patient’s age at diagnosis and data of the internal and external
genitalia, as in most cases of genital ambiguity. When diag-
nosed at early ages, the best option is female sex of rearing,
trying to maintain the ovarian portion of the gonads when
possible, regarding the possibility of spontaneous female
puberty and fertility, especially in patients with chromosomal
46,XX constitution [38]. Cases of 46,XX ovotesticular DSD
and 46,XX testicular DSD were seen in the same family, in
monozygotic twins, suggesting that these two disorders can
have one etiology with a broad phenotypic spectrum [40].
Less frequent etiologies of DGD in this series were 46,XX tes-
ticular DSD [41] and testicular regression syndrome [42, 43].
Furthermore, there were 19 that were evaluated by pre-
senting a genital complex malformation (not ambiguous
genitalia) especially associated with vertebral, urinary, and
intestinal tract alterations [44]. Abnormal development of
external genitalia may be an isolated anomaly but can also
be part of abnormalities in the development of the lower
abdominal wall or perineum. As described by Cox et al. [10]
and Hutson et al. [15], the investigation of DSD defects in
these patients is essential and possibly more often necessary
than described in the literature.
Sex assignments before referral to our service and before
etiological investigation, in addition to older age at the
first visit to our hospital (average of 31.7 months), show
that pediatricians need to understand better the concept of
DSD and its etiologies as well as clinical and psychosocial
implications [45]. The average age at first visit was signifi-
cantly lower in the 46,XX ovarian DSD group, which may
be explained by the large number of cases of 21𝛼-hydroxy-
lase deficiency in the salt-wasting form, for whom the risk
of death is high if it is not early diagnosed. Only 27 cases
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(6.6%) have sex reassignment, 15 frommale to female (mainly
cases of congenital adrenal hyperplasia, mixed gonadal dys-
genesis, and 46,XX ovotesticular DSD) and 12 from female
to male (mainly 5-alpha-reductase type 2 deficiency). Sex
reassignment occurred in the first year of life in all cases,
except for patients with 5𝛼-reductase type 2 deficiency.
About half of the cases of sex reassignment were due to the
possibility of normal female puberty and fertility in patients
with congenital adrenal hyperplasia (seven cases) and to
personal request of adolescents with 5𝛼-reductase type 2
deficiency (seven cases), as recommended by Consensus of
DSD [1, 2]. In patients with genital ambiguity due to mixed
gonadal dysgenesis or ovotesticular DSD, sex definition is
a challenge involving prognosis about adult gender identity,
anticipated quality of sexual function, surgical options and
risks, fertility potential, evidence of fetal CNS exposure
to androgens, gonadal malignancy risk, and psychosocial
factors (familial, social, and cultural) [1, 2]. In this present
study, five patients with mixed gonadal dysgenesis and four
patients with ovotesticular DSD (three with 46,XX karyotype
e and onewith 46,XY karyotype) had sex reassignment, based
on surgical options (severity of genital ambiguity), presence
of normal uterus, and decision of the family.
Overall, the predominant sex assigned was male (238
cases), following the increased frequency of karyotype 46,XY
and the high number of cases of 46,XY testicular DSD.
5. Conclusions
With the experience of treating and following 408 DSD
patients with genital ambiguity over 23 years in an inter-
disciplinary care center, we may conclude that individuals
with genital ambiguity represent an urgent problem thatmust
be solved quickly and accurately, as early as possible. The
management of these patients requires empathy and should
be performed by a skilled multidisciplinary team, in order
to reach a correct diagnosis without confusion about the
child’s sexual identification. Making a diagnosis properly
before the sex assignment in most cases gives the patient
and the family a better understanding of the condition and
the proper definition of gender of rearing and allows more
satisfaction with treatment. This study with a large sample
shows that it is essential for the general pediatricians, who
are the first professionals to evaluate the child, to have at least
basic knowledge of DSD. Inadequate sex assignments and
ineffective treatments may occur if these rare conditions are
not properly evaluated.
It can also be concluded that the 46,XY karyotype was
more frequent among cases of DSD whereas congenital
adrenal hyperplasia was themost common etiology ofmono-
genic inheritance. Cases of 46,XY DSD and DGD require
much attention and accurate laboratorial tests for the correct
etiological diagnosis. Other malformations were commonly
associated in all DSD groups. Several cases without etiologic
diagnosis or with syndromic features need advanced tech-
nique like next generation sequencing, with either panels
of candidate genes or whole exome, making it possible to
clarify the etiologic diagnosis and to discover new candidate
genes, mainly in 46,XY testicular DSD. Low birth weight was
associated with the 46,XY testicular DSD. The average age at
the first visit was 31.7 months and was lower in the 46,XX
DSD group. The final sex of rearing was male in 238 cases
and female in 170, and only 6.6% had sex reassignment.
Finally, we want to emphasize the importance of knowing
the prevalence of each etiologic diagnosis of DSD with
ambiguous genitalia and the use of both karyotype and
gonadal tissue in the classification of DSD groups.
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